Off-Label Therapies for COVID-19-Are We All In This Together?
- PMID: 32311763
- PMCID: PMC7264670
- DOI: 10.1002/cpt.1862
Off-Label Therapies for COVID-19-Are We All In This Together?
Conflict of interest statement
The authors declared no conflict of interest.
Similar articles
-
Drug Evaluation during the Covid-19 Pandemic.N Engl J Med. 2020 Jun 11;382(24):2282-2284. doi: 10.1056/NEJMp2009457. Epub 2020 Apr 14. N Engl J Med. 2020. PMID: 32289216 No abstract available.
-
Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.Am J Med. 2020 Sep;133(9):1007-1008. doi: 10.1016/j.amjmed.2020.05.005. Epub 2020 Jun 2. Am J Med. 2020. PMID: 32502485 Free PMC article. No abstract available.
-
Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.JAMA. 2020 Oct 6;324(13):1282-1283. doi: 10.1001/jama.2020.16253. JAMA. 2020. PMID: 32870235 No abstract available.
-
Hydroxychloroquine and coronavirus disease 2019.J R Coll Physicians Edinb. 2020 Jun;50(2):102-104. doi: 10.4997/JRCPE.2020.202. J R Coll Physicians Edinb. 2020. PMID: 32568274 Review. No abstract available.
-
BET 2: Hydroxychloroquine in the treatment of COVID-19.Emerg Med J. 2020 Jul;37(7):451-453. doi: 10.1136/emermed-2020-210221.3. Emerg Med J. 2020. PMID: 32616659 Review. No abstract available.
Cited by
-
Remdesivir for the treatment of COVID-19.Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2. Cochrane Database Syst Rev. 2023. PMID: 36695483 Free PMC article. Review.
-
Assessment of novel technologies in healthcare - off-label use of drugs and the ethics of implementation and distribution of COVID-19 vaccines.Einstein (Sao Paulo). 2022 Jan 5;19:eED6840. doi: 10.31744/einstein_journal/2021ED6840. Einstein (Sao Paulo). 2022. PMID: 35019043 Free PMC article. No abstract available.
-
Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations.Hastings Cent Rep. 2021 Nov;51(6):27-32. doi: 10.1002/hast.1296. Epub 2021 Nov 8. Hastings Cent Rep. 2021. PMID: 34750807 Free PMC article.
-
Remdesivir for the treatment of COVID-19.Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2023 Jan 25;1:CD014962. doi: 10.1002/14651858.CD014962.pub2. PMID: 34350582 Free PMC article. Updated.
-
Inflammatory arthritis in patients with COVID-19.Transl Res. 2021 Jun;232:49-59. doi: 10.1016/j.trsl.2021.02.010. Epub 2021 Feb 21. Transl Res. 2021. PMID: 33626415 Free PMC article. Review.
References
-
- Kupferschmidt, K. & Cohen, J. Race to find COVID‐19 treatments accelerates. Science 367, 1412–1413 (2020). - PubMed
-
- McCreary, E. & Pogue, J.M. COVID‐19 treatment: a review of early and emerging options. Open forum infectious diseases <https://academic.oup.com/ofid/advance‐article/doi/10.1093/ofid/ofaa105/5...>. Accessed March 24, 2020. - DOI - PMC - PubMed
-
- Bloomberg . Hospitals stockpile drug trump says could treat Covid‐19 <https://www.bloomberg.com/news/articles/2020‐03‐20/hospitals‐stockpile‐m...>.
-
- Kalil, A.C. Lack of benefit of high‐dose vitamin C, thiamine, and hydrocortisone combination for patients with sepsis. JAMA 323, 419–420 (2020) <https://jamanetwork.com/journals/jama/article‐abstract/2759413>. - PubMed
-
- US Food and Drug Administration . Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. <https://www.fda.gov/media/136534/download>.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources